BrightSpring Stock Soars 12%, Adding $1.4 Billion, As Company Raises 2026 Revenue Forecast

Third-quarter revenue climbed 26.4% to $4.21 billion, and BrightSpring raised its 2026 revenue and adjusted EBITDA guidance.

Share
BrightSpring Stock Soars 12%, Adding $1.4 Billion, As Company Raises 2026 Revenue Forecast

BrightSpring Health Services, which provides pharmacy and in-home care to medically complex patients, saw its shares climb 12.12% to $67.52 in Friday trading, as of 9:51 a.m. ET, adding $1.4 billion in market value. The move came the day the company raised its 2026 forecast after third-quarter revenue grew 26.4% from a year earlier to $4.21 billion.

A raised outlook and a tripled profit

Adjusted earnings came to $0.54 per share, the company said in its press release. Net income for the quarter ended September 30 was $100.1 million, and profit from continuing operations nearly tripled.

New full-year revenue guidance of $15,900 million to $16,125 million implies growth of 23.2% to 24.9%, according to the same report. The company also lifted its adjusted EBITDA outlook, and leverage fell to 1.79x.

The stock was on pace for its third straight daily gain and its biggest one-day gain in at least 275 trading sessions, since Sept. 26, 2025.

A pharmacy and home-care business

BrightSpring reports two segments, Pharmacy Solutions and Provider Services, according to its annual report. Its pharmacies, more than 175 of them, deliver drugs including infusion and oncology specialty medications. Its provider arm covers home health, hospice, rehab therapy, personal care and home-based primary care.

The company operates in all 50 states and serves over 465,000 patients at any one time. Patients are largely covered by Medicare, Medicaid or commercial insurance.

A 61% run before results

BrightSpring shares were up about 61% year to date at Thursday's close, against about 13% for the S&P 500. That left the stock 8% below its 52-week high of $73.75 before the results.

Management had flagged pressure on its home and community pharmacy business from the Inflation Reduction Act, which it expected to trim about $45 million from third-quarter revenue.

The shares' $67.52 price in Friday trading sits below the $73.75 52-week high they were 8% short of at Thursday's close.

Sources

More on BrightSpring Health Services

All BrightSpring Health Services (BTSG) coverage →